ZIIHERA: payments to doctors
Payments that named ZIIHERA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 1,406
- Transactions
- 2,334
- Average per transaction
- $462
The per-transaction average — $462 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,406 providers the average total is $768, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| JAZZ Pharmaceuticals Inc. | $1,079,416 | 100.0% |
| Jazz Pharmaceuticals Inc. | $44 | 0.0% |